Abstract
BackgroundCorticosteroids are a potential therapeutic agent for patients with COVID-19 pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data on the mortality benefits of corticosteroids. The study aimed...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have